Kevin T. Conroy
Director · ABBOTT LABORATORIES
IndividualBuying only
- 2024
- Oct 2, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin T. Conroy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert B. Ford - $48.22M in ABT purchases and sales in the last 12 months
- Daniel J. Starks - $2.01M in ABT purchases and sales in the last 12 months
- Louis H. Morrone - $775K in ABT purchases and sales in the last 12 months
- Eric Shroff - $285K in ABT purchases and sales in the last 12 months
- Philip P. Boudreau - $201K in ABT purchases and sales in the last 12 months
- John G. Stratton - $174K in ABT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin T. Conroy?
Kevin T. Conroy is a corporate insider, tracked as Director of ABBOTT LABORATORIES (ABT). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kevin T. Conroy submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kevin T. Conroy been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1.00M) and 0 open-market sales across all tracked filings.
